Health X Platform Ltd
Health X Platform Q4 FY26: Capex ₹234 Cr
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Health X Platform targets ₹6,000 crore revenue by FY30, with ₹4,000 crore from B2B Retailer Shakti and ₹2,000 crore from B2C Sasta Sundar (Page 3). FY27 and FY28 ROE expected to be low/negative due to initial investments and losses.
From Health X Platform Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Health X Platform targets ₹6,000 crore revenue by FY30, with ₹4,000 crore from B2B Retailer Shakti and ₹2,000 crore from B2C Sasta Sundar (Page 3).
- Retailer Shakti aims for around ₹1,700 crore revenue in FY27, with Q1 FY27 expected at ₹400 crore—the best in company history (Pages 12-13).
- Warehousing expansions from 2.5 lakh to over 8 lakh square feet planned by FY27 to support growth (Page 13).
- Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10).
- JITO private-label margins expected at 30–40% with initial market response better than expected (Page 11).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Health X Platform Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Total planned capex for warehouse expansion is ₹234 crores (Page 11, 10).
- Out of ₹234 crores, ₹134 crores planned through bank loans and ₹100 crores from treasury (Page 10).
- Additional warehouse capacity of 1 lakh sq. ft. to go live by March FY27; current capacity 2.5 lakh sq. ft. and plans to build 4 lakh sq. ft. more (Page 13).
- Further plan to build 5.52 lakh sq. ft. additional warehouse capacity in Udaipur, Lucknow, Patna, Guwahati, Baripur, totaling over 8 lakh sq. ft. warehouse capacity (Page 13).
- Investment of ₹150 crores in AI and tech platforms; ₹75 crores already deployed with ₹75 crores more to be invested (Page 5).
2 more points management made on capital expenditure plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Health X Platform Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders for Health X Platform Limited.
- Focus areas highlighted include:
- Expansion of warehousing capacity (additional 1 lakh sq ft by March 2027, and plans to build 4 lakh more sq ft).
- Growth targets with revenue expected to reach ₹6,000 crores by FY2030.
- Ongoing initiatives like JITO, Retailer Shakti, and HealthBuddy being scaled.
- Plans for AI applications and cautious deployment of capital in technology.
2 more points management made on order book & pipeline
Health X Platform Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹346 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Health X Platform Ltd's management said in earlier quarters
Others in Healthcare Services this season
- KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
- Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
- Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…
Frequently Asked Questions
What were Health X Platform Ltd Q4 FY26 results?
Health X Platform targets ₹6,000 crore revenue by FY30, with ₹4,000 crore from B2B Retailer Shakti and ₹2,000 crore from B2C Sasta Sundar (Page 3). FY27 and FY28 ROE expected to be low/negative due to initial investments and losses.
What is Health X Platform Ltd share price analysis?
Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.
Is Health X Platform Ltd planning capital expenditure?
Total planned capex for warehouse expansion is ₹234 crores (Page 11, 10). - Out of ₹234 crores, ₹134 crores planned through bank loans and ₹100 crores from treasury (Page 10). - Additional warehouse capacity of 1 lakh sq.
Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.